TTM Congress Reviewed in Journal ICU Management.

CINCINNATI -- The newest issue of ICU Management, the official voice of the International Symposium on Intensive Care and Emergency Medicine (ISICEM), features a comprehensive review of the 1st Annual International Therapeutic Temperature Management Congress (TTM Congress) by Dr. Kees Polderman, Vice Chairman, Department of Intensive Care, University Medical Center, Utrecht, Netherlands, and Lead Faculty of the Congress.

Showcasing the most recent clinical developments and therapies, ICU Management captures best-practice, cost-efficiency, and patient/staff-satisfaction trends in critical care and emergency medicine. The publication draws on the expertise of several important organizations, including the European Society of Intensive Care Medicine, the ECRI Institute, and the Society for Critical Care Medicine (SCCM).

The current ICU Management edition (Volume 7, Issue 4) focuses on critical care and emergency medicine safety, an area in which induced hypothermia therapy benefits increasingly are credited - and around which the TTM Congress was commenced. Dr. Polderman's review, "Induced Hypothermia & Neurological Outcome: The 1(st) Therapeutic Temperature Management Congress," highlights the growing adoption of therapeutic hypothermia in the critical-care and emergency-medicine fields as well as the particular tracks of discussion and inquiry guiding the leading best-practice protocols to date and ongoing.

Remarked Dr. Polderman, "ICU Management is dedicated to improving critical patient therapy and delivery effectiveness through dissemination of important information. Induced hypothermia and the TTM Congress find their origins in this very issue: for a variety of applications, cooling solutions are associated with improved neurological outcome for critical patients; the TTM Congress will continue to serve as an expert, collaborative resource, available to advance understanding and impact in this important treatment area."

In response to the publication release, Mark Beran, Vice President and General Manager of CSZ Medical, founding TTM Congress sponsor and a developer of advanced patient temperature management systems, including highly effective and efficient cooling products, remarked "Medical journal and other publication coverage of the congress is quite simply an additional validation of the value in these therapies. We are working alongside the medical community and with other sponsors to produce an even more remarkable event in 2008."

The 2nd Annual TTM Congress (TTM Congress 2008) is to be held in Barcelona, Spain from October 1st-4th, 2008. For additional details, please visit www.ttmcongress2008.com. For more information on or to obtain a copy of the ICU Management journal, please visit www.icu-management.org. Copies of the current issue will be distributed at the upcoming SCCM annual meeting, The 37th Critical Care Congress, February 2nd-6th in Honolulu, Hawaii. For more information on the meeting, please visit www.sccm.org.

About Cincinnati Sub-Zero and Cincinnati Sub-Zero, Medical Division

The parent of three separate divisions, Cincinnati Sub-Zero (CSZ) is a leading manufacturer and provider of temperature management products for medical and industrial needs. Cincinnati Sub-Zero, Medical Division has delivered patient temperature management systems to healthcare professionals since 1963, always designed with the patient in mind. The complete line of products includes therapeutic heat therapy, cold therapy units along with a complete line of warming blankets and cooling blankets for body temperature regulation and hyper-hypothermia treatment. Please visit www.cszinc.com to learn more about CSZ and www.cszmedical.com to learn more about CSZ Medical.

Forward-Looking Statements 

Except for statements of historical fact, the matters discussed in this press release are forward-looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.